N. Schrameijer

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. (2006)

Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Pieter [1196], Schrameijer, N., ...

Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. (2006)

Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Pieter [1196], Schrameijer, N., ...

Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. (2006)

Lems, W., Lodder, M., Lips, P., Bijlsma, J., GEUSENS, Piet, Schrameijer, N., ...

Alendronate has been described to have a bone-sparing effect in patients treated with moderate and high dosages of prednisone for heterogeneous diseases, however no data are available on groups of...